Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-07-08

Clinical Trial Update: Botulinum Toxin for Pelvic Pain in Women With Endometriosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating botulinum toxin for pelvic pain in women with endometriosis completed phases 1 and 2; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Endometriosis, Chronic Pelvic Pain | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-08